Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Harnessing Biomaterials to Engineer the Lymph Node Microenvironment for Immunity or Tolerance
James I. Andorko, Krystina L. Hess, Christopher M. Jewell
The AAPS Journal (2014) Vol. 17, Iss. 2, pp. 323-338
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity
Natalie L. Trevaskis, Lisa M. Kaminskas, Christopher J. H. Porter
Nature Reviews Drug Discovery (2015) Vol. 14, Iss. 11, pp. 781-803
Open Access | Times Cited: 571
Lymphatic Vessel Network Structure and Physiology
Jerome W. Breslin, Ying Yang, Joshua P. Scallan, et al.
Comprehensive physiology (2018), pp. 207-299
Open Access | Times Cited: 308
Lymph node targeting strategies to improve vaccination efficacy
Hao Jiang, Qin Wang, Xun Sun
Journal of Controlled Release (2017) Vol. 267, pp. 47-56
Closed Access | Times Cited: 249
Designing biomaterials with immunomodulatory properties for tissue engineering and regenerative medicine
James I. Andorko, Christopher M. Jewell
Bioengineering & Translational Medicine (2017) Vol. 2, Iss. 2, pp. 139-155
Open Access | Times Cited: 177
Biomaterials for vaccine-based cancer immunotherapy
Rui Zhang, Margaret M. Billingsley, Michael J. Mitchell
Journal of Controlled Release (2018) Vol. 292, pp. 256-276
Open Access | Times Cited: 173
Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice
Yudong Song, Luke F. Bugada, Ruiting Li, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 643
Open Access | Times Cited: 74
Improving Vaccine and Immunotherapy Design Using Biomaterials
Michelle L. Bookstaver, Shannon J. Tsai, Jonathan S. Bromberg, et al.
Trends in Immunology (2017) Vol. 39, Iss. 2, pp. 135-150
Open Access | Times Cited: 166
Smart Biomaterials: Recent Advances and Future Directions
Piotr S. Kowalski, Chandrabali Bhattacharya, Samson Afewerki, et al.
ACS Biomaterials Science & Engineering (2018) Vol. 4, Iss. 11, pp. 3809-3817
Closed Access | Times Cited: 157
Polyelectrolyte Multilayers Assembled Entirely from Immune Signals on Gold Nanoparticle Templates Promote Antigen-Specific T Cell Response
Peipei Zhang, Yu-Chieh Chiu, Lisa H. Tostanoski, et al.
ACS Nano (2015) Vol. 9, Iss. 6, pp. 6465-6477
Open Access | Times Cited: 149
Reprogramming the Local Lymph Node Microenvironment Promotes Tolerance that Is Systemic and Antigen Specific
Lisa H. Tostanoski, Yu-Chieh Chiu, Joshua M. Gammon, et al.
Cell Reports (2016) Vol. 16, Iss. 11, pp. 2940-2952
Open Access | Times Cited: 136
Engineering nanoparticles to overcome barriers to immunotherapy
Randall Toy, Krishnendu Roy
Bioengineering & Translational Medicine (2016) Vol. 1, Iss. 1, pp. 47-62
Open Access | Times Cited: 133
Designing inorganic nanomaterials for vaccines and immunotherapies
Krystina L. Hess, Igor L. Medintz, Christopher M. Jewell
Nano Today (2019) Vol. 27, pp. 73-98
Open Access | Times Cited: 131
Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy: Restoring the immunogenicity of immunosilent mRNA
R Verbeke, Ine Lentacker, Laura Wayteck, et al.
Journal of Controlled Release (2017) Vol. 266, pp. 287-300
Closed Access | Times Cited: 112
Progress and opportunities for enhancing the delivery and efficacy of checkpoint inhibitors for cancer immunotherapy
David M. Francis, Susan N. Thomas
Advanced Drug Delivery Reviews (2017) Vol. 114, pp. 33-42
Open Access | Times Cited: 93
Nanovaccine‐Based Strategies to Overcome Challenges in the Whole Vaccination Cascade for Tumor Immunotherapy
Lin Qin, Huilin Zhang, Yang Zhou, et al.
Small (2021) Vol. 17, Iss. 28
Closed Access | Times Cited: 87
Viral-mimicking protein nanoparticle vaccine for eliciting anti-tumor responses
N Molino, Medea Neek, Jo A. Tucker, et al.
Biomaterials (2016) Vol. 86, pp. 83-91
Open Access | Times Cited: 86
Designing natural and synthetic immune tissues
Emily A. Gosselin, Haleigh B. Eppler, Jonathan S. Bromberg, et al.
Nature Materials (2018) Vol. 17, Iss. 6, pp. 484-498
Open Access | Times Cited: 86
Effect of physicochemical properties on in vivo fate of nanoparticle-based cancer immunotherapies
Yongchao Wang, Jinjin Wang, Dandan Zhu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 4, pp. 886-902
Open Access | Times Cited: 67
Nanomedicine for T‐Cell Mediated Immunotherapy
Fangzhou Li, Jiang Ouyang, Zuqin Chen, et al.
Advanced Materials (2023) Vol. 36, Iss. 22
Closed Access | Times Cited: 26
Intrinsic immunogenicity of rapidly-degradable polymers evolves during degradation
James I. Andorko, Krystina L. Hess, Kevin Pineault, et al.
Acta Biomaterialia (2015) Vol. 32, pp. 24-34
Open Access | Times Cited: 88
In Vivo Expansion of Melanoma-Specific T Cells Using Microneedle Arrays Coated with Immune-Polyelectrolyte Multilayers
Qin Zeng, Joshua M. Gammon, Lisa H. Tostanoski, et al.
ACS Biomaterials Science & Engineering (2016) Vol. 3, Iss. 2, pp. 195-205
Open Access | Times Cited: 84
Engineering Immunological Tolerance Using Quantum Dots to Tune the Density of Self‐Antigen Display
Krystina L. Hess, Eunkeu Oh, Lisa H. Tostanoski, et al.
Advanced Functional Materials (2017) Vol. 27, Iss. 22
Open Access | Times Cited: 73
Combining antigen and immunomodulators: Emerging trends in antigen-specific immunotherapy for autoimmunity
Laura Northrup, Matthew A. Christopher, Bradley P. Sullivan, et al.
Advanced Drug Delivery Reviews (2015) Vol. 98, pp. 86-98
Closed Access | Times Cited: 68
Inorganic Nanomaterial‐Mediated Gene Therapy in Combination with Other Antitumor Treatment Modalities
Guanyou Lin, Richard A. Revia, Miqin Zhang
Advanced Functional Materials (2020) Vol. 31, Iss. 5
Open Access | Times Cited: 66
Biomaterial-based delivery platforms for transdermal immunotherapy
Mohammad Dahri, Nima Beheshtizadeh, Nasrin Seyedpour, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115048-115048
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top